Abstract: The present disclosure relates to methods for reducing host cell protein content in antibody preparation recombinantly produced in a host cell in the manufacturing process of antibodies intended for administration to a patient. The disclosed methods may be performed in order to prepare therapeutic antibody preparations having reduced host cell protein.
| # | Name | Date |
|---|---|---|
| 1 | 202317027267.pdf | 2023-04-13 |
| 2 | 202317027267-STATEMENT OF UNDERTAKING (FORM 3) [13-04-2023(online)].pdf | 2023-04-13 |
| 3 | 202317027267-Sequence Listing in txt [13-04-2023(online)].txt | 2023-04-13 |
| 4 | 202317027267-Sequence Listing in PDF [13-04-2023(online)].pdf | 2023-04-13 |
| 5 | 202317027267-REQUEST FOR EXAMINATION (FORM-18) [13-04-2023(online)].pdf | 2023-04-13 |
| 6 | 202317027267-POWER OF AUTHORITY [13-04-2023(online)].pdf | 2023-04-13 |
| 7 | 202317027267-FORM-26 [13-04-2023(online)].pdf | 2023-04-13 |
| 8 | 202317027267-FORM 18 [13-04-2023(online)].pdf | 2023-04-13 |
| 9 | 202317027267-FORM 1 [13-04-2023(online)].pdf | 2023-04-13 |
| 10 | 202317027267-DECLARATION OF INVENTORSHIP (FORM 5) [13-04-2023(online)].pdf | 2023-04-13 |
| 11 | 202317027267-COMPLETE SPECIFICATION [13-04-2023(online)].pdf | 2023-04-13 |
| 12 | 202317027267-Proof of Right [11-10-2023(online)].pdf | 2023-10-11 |
| 13 | 202317027267-FORM 3 [11-10-2023(online)].pdf | 2023-10-11 |